Agios Pharma (AGIO) Misses Q2 EPS by 12c

Agios Pharma (NASDAQ: AGIO) reported Q2 EPS of ($1.93), $0.12 worse than the analyst estimate of ($1.81). Revenue for the quarter came in at $12.45 million versus the consensus estimate of $9.54 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Duerr AG (DUE:GR) (DURYY) PT Lowered to EUR21 at Deutsche Bank
• Correction: Kepler Cheuvreux Upgrades Siemens AG (SIE:GR) (SIEGY) to Hold